DB-1324

· DualityBio Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DB-1324, covering 2025-12-04 to 2025-12-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors [Phase 1, Phase 2]